Related references
Note: Only part of the references are listed.MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer
Ammar Sarwar et al.
BIOCHEMICAL PHARMACOLOGY (2021)
MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism
An Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
Concetta Panebianco et al.
BIOMOLECULES (2021)
Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis
Malgorzata Guz et al.
BIOMEDICAL REPORTS (2021)
Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD)
Camilla Mattiuzzi et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2020)
miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6
Rong Cao et al.
CELL CYCLE (2020)
MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer
Xiaowei Fu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis
Mei-Juan Tu et al.
MOLECULAR PHARMACOLOGY (2020)
The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells
Daisuke Namima et al.
IN VIVO (2020)
MiR-137 promotes anoikis through modulating the AKT signaling pathways in Pancreatic Cancer
Lin Li et al.
JOURNAL OF CANCER (2020)
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Douglas E. Biancur et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Personalized RNA Medicine for Pancreatic Cancer
Maud-Emmanuelle Gilles et al.
CLINICAL CANCER RESEARCH (2018)
Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
Hao Wang et al.
CLINICAL EPIGENETICS (2018)
microRNA based prognostic biomarkers in pancreatic Cancer
Shixiang Guo et al.
BIOMARKER RESEARCH (2018)
MicroRNAs in pancreatic cancer diagnosis and therapy
Robert Slotwinski et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
Mohammad Aslam Khan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility
Erine H. Budi et al.
TRENDS IN CELL BIOLOGY (2017)
The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster
Keiichi Yonemori et al.
ONCOTARGET (2017)
Methods and novel technology for microRNA quantification in colorectal cancer screening
Laura Moody et al.
CLINICAL EPIGENETICS (2017)
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Nicolas Jonckheere et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer
Yiwei Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value
Junghyun Namkung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Pancreatic cancer biology and genetics from an evolutionary perspective
Alvin Makohon-Moore et al.
NATURE REVIEWS CANCER (2016)
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer
Satyanarayana Rachagani et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
p53, a translational regulator: contribution to its tumour-suppressor activity
V. Marcel et al.
ONCOGENE (2015)
Peroxiredoxin 1 Promotes Pancreatic Cancer Cell Invasion by Modulating p38 MAPK Activity
Keisuke Taniuchi et al.
PANCREAS (2015)
Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway
Xiaolin Nan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Structural determinants of Smad function in TGF-β signaling
Maria J. Macias et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
Makoto Abue et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers
Renata A. Rawlings-Goss et al.
BMC MEDICAL GENOMICS (2014)
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
S. Hasegawa et al.
BRITISH JOURNAL OF CANCER (2014)
Functional p38 MAPK Identified by Biomarker Profiling of Pancreatic Cancer Restrains Growth through JNK Inhibition and Correlates with Improved Survival
Yi Zhong et al.
CLINICAL CANCER RESEARCH (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
MIR-211 MODULATES GEMCITABINE ACTIVITY THROUGH DOWNREGULATION OF RIBONUCLEOTIDE REDUCTASE AND INHIBITS THE INVASIVE BEHAVIOR OF PANCREATIC CANCER CELLS
Mina Maftouh et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2014)
A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer
Alakesh Bera et al.
PLOS ONE (2014)
MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer
Sheema Khan et al.
ONCOTARGET (2014)
It can't be very important because it comes and goes-patients' accounts of intermittent symptoms preceding a pancreatic cancer diagnosis: a qualitative study
Julie Evans et al.
BMJ OPEN (2014)
MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens
Tae Ho Hong et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2014)
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
Y. Iwagami et al.
BRITISH JOURNAL OF CANCER (2013)
miRNA profiling in pancreatic cancer and restoration of chemosensitivity
Saurabh Singh et al.
CANCER LETTERS (2013)
miRNA in clinical practice: Pancreatic cancer
Marine Humeau et al.
CLINICAL BIOCHEMISTRY (2013)
Prospects of miRNA-Based Therapy for Pancreatic Cancer
Priya Pai et al.
CURRENT DRUG TARGETS (2013)
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
Jordan M. Winter et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
Zhiyu Chen et al.
MOLECULAR CANCER (2013)
Control of cell cycle transcription during G1 and S phases
Cosetta Bertoli et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1
Chen Huang et al.
ONCOLOGY REPORTS (2013)
Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein
Yangzom Doma Bhutia et al.
PLOS ONE (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
Hai-jiao Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Biological and Prognostic Relevance of Mitogen-Activated Protein Kinases in Pancreatic Adenocarcinoma
Adriana Handra-Luca et al.
PANCREAS (2012)
Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
Meredith A. Collins et al.
PLOS ONE (2012)
miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway
Yongjun Hu et al.
TUMOR BIOLOGY (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells
Jie Dong et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
Jong-Kook Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells
Sanjeev K. Srivastava et al.
CARCINOGENESIS (2011)
Analyzing miRNAs in Ductal Adenocarcinomas of the Pancreas
Soeren Torge Mees et al.
JOURNAL OF SURGICAL RESEARCH (2011)
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis
Kohei Nakata et al.
SURGERY (2011)
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review
Umashankar K. Ballehaninna et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2011)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
Oliver A. Kent et al.
GENES & DEVELOPMENT (2010)
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
Thomas Greither et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Small Molecule Modifiers of MicroRNA miR-122 Function for the Treatment of Hepatitis C Virus Infection and Hepatocellular Carcinoma
Douglas D. Young et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
Jun Yu et al.
MOLECULAR CANCER (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
Nils Habbe et al.
CANCER BIOLOGY & THERAPY (2009)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Retinoic Acid Receptor Antagonists Inhibit miR-10a Expression and Block Metastatic Behavior of Pancreatic Cancer
Frank Ulrich Weiss et al.
GASTROENTEROLOGY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Potent inhibition of microRNA in vivo without degradation
Scott Davis et al.
NUCLEIC ACIDS RESEARCH (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis
Yuqing Zhang et al.
WORLD JOURNAL OF SURGERY (2009)
Small-molecule inhibitors of microRNA miR-21 function
Kiranmai Gumireddy et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Inhibition of microRNA with antisense oligonucleotides
Christine C. Esau
METHODS (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Jon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Epigenetic activation of tumor suppressor microRNAs in human cancer cells
Yoshimasa Saito et al.
CELL CYCLE (2006)
Improved targeting of miRNA with antisense oligonucleotides
Scott Davis et al.
NUCLEIC ACIDS RESEARCH (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Surgery for pancreatic cancer: Recent controversies and current practice
CJ Wray et al.
GASTROENTEROLOGY (2005)
MicroRNA biogenesis: Coordinated cropping and dicing
VN Kim
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Ras redux: rethinking how and where Ras acts
SR Hingorani et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2003)
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
PM Siegel et al.
NATURE REVIEWS CANCER (2003)
Share Paper
